within Pharmacolibrary.Drugs.ATC.G;

model G02AD02
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 4.1666666666666665e-05,
    adminDuration  = 600,
    adminMass      = 10 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0005,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>G02AD02</td></tr><td>route:</td><td>vaginal</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Dinoprostone is a synthetic prostaglandin E2 (PGE2) analog used primarily for cervical ripening and labor induction in obstetrics. It is also employed in the management of missed abortion or for evacuation of the uterus. Dinoprostone is an approved medication and is still widely used today, administered via vaginal, endocervical, or rectal routes.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters are mainly based on published pharmacokinetic studies performed in healthy nonpregnant and pregnant women, with administration predominantly via vaginal or suppository route.</p><h4>References</h4><ol><li><p>Shirley, M (2018). Dinoprostone Vaginal Insert: A Review in Cervical Ripening. <i>Drugs</i> 78(15) 1615–1624. DOI:<a href=\"https://doi.org/10.1007/s40265-018-0995-2\">10.1007/s40265-018-0995-2</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/30317521/\">https://pubmed.ncbi.nlm.nih.gov/30317521</a></p></li><li><p>Bygdeman, M (2003). Pharmacokinetics of prostaglandins. <i>Best practice &amp; research. Clinical obstetrics &amp; gynaecology</i> 17(5) 707–716. DOI:<a href=\"https://doi.org/10.1016/s1521-6934(03)00043-9\">10.1016/s1521-6934(03)00043-9</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/12972009/\">https://pubmed.ncbi.nlm.nih.gov/12972009</a></p></li><li><p>Yayla Abide, Ç, et al., &amp; Eroğlu, M (2018). Effect of vaginal washing before intravaginal dinoprostone insertion for labor induction: A randomized clinical trial. <i>The journal of obstetrics and gynaecology research</i> 44(12) 2149–2155. DOI:<a href=\"https://doi.org/10.1111/jog.13777\">10.1111/jog.13777</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/30094885/\">https://pubmed.ncbi.nlm.nih.gov/30094885</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end G02AD02;
